Table 2 Comparison of clinical and demographic characteristics of patients with LRE-persistence and LRE-clearance
Characteristic | LRE-persistence | LRE-clearance | p-value* |
|---|---|---|---|
Sex (male) | 5 (71%) | 23 (59%) | 0.33 |
Age [years] | 58 (32–77) | 62 (23–83) | 0.78 |
Oncological disease | 3 (43%) | 21 (54%) | 0.07 |
Immunodeficiency | 5 (71%) | 31 (79%) | 0.53 |
Antibiotic treatment | 6 (86%) | 29 (74%) | 0.31 |
Liver dysfunction | 3 (43%) | 7 (18%) | 0.18 |
Kidney dysfunction | 5 (71%) | 16 (41%) | 0.20 |
Admission from another hospital | 1 (14%) | 8 (21%) | 0.30 |
Hospitalization on an ICU | 2 (28%) | 15 (38%) | 0.13 |
Duration of hospitalization [days] | 110 (28–225) | 53 (5–213) | 0.02 |